Rein Therapeutics (RNTX) Other Working Capital Changes (2024 - 2025)
Rein Therapeutics (RNTX) posted quarterly Other Working Capital Changes of -$103000.0 for Q1 2026, down 182.4% year-over-year from $125000.0 in Q1 2025, and down 132.29% quarter-over-quarter from $319000.0 in Q4 2025.
Rein Therapeutics (RNTX) Other Working Capital Changes (2024 - 2025) Analysis & Trends
Rein Therapeutics (RNTX) has reported Other Working Capital Changes for 11 consecutive years, with -$103000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 182.4% year-over-year to -$103000.0; the TTM figure through Mar 2026 stood at $91000.0 (down 93.4% YoY), while the FY2025 annual figure was $319000.0, up 764.58% from the prior year.
- Other Working Capital Changes retreated to -$277000.0 in Q1 2025 per RNTX's latest filing, from $277000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.6 million in Q3 2024 and bottomed at -$1.3 million in Q1 2024.
- Historically, Other Working Capital Changes has averaged $2625.0 across 5 years, with a median of -$32000.0 in 2022.
- On a YoY basis, Other Working Capital Changes climbed as much as 17377.78% in 2024 and fell as far as 3842.42% in 2024.
- Rein Therapeutics' Other Working Capital Changes stood at $277000.0 in 2024, then slumped by 200.0% to -$277000.0 in 2025.
- Business Quant data shows RNTX's Other Working Capital Changes at -$277000.0 in Q1 2025, $277000.0 in Q4 2024, and -$116000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Rein Therapeutics | 54.35 Mn | 54.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -277,000.00 |
| Mar 31, 2025 | -277,000.00 |
| Mar 31, 2025 | -277,000.00 |
| Dec 31, 2024 | 277,000.00 |
| Dec 31, 2024 | 277,000.00 |
| Dec 31, 2024 | 277,000.00 |
| Sep 30, 2024 | -116,000.00 |
| Sep 30, 2024 | -116,000.00 |
| Sep 30, 2024 | -116,000.00 |